Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Colorcon
Moodys
Express Scripts
McKinsey

Last Updated: February 9, 2023

SODIUM POLYSTYRENE SULFONATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for sodium polystyrene sulfonate and what is the scope of patent protection?

Sodium polystyrene sulfonate is the generic ingredient in five branded drugs marketed by Kvk Tech, Concordia, Ani Pharms, Aiping Life Sci, Belcher, Chartwell Rx, Citrusphrma, Cmp Pharma Inc, Epic Pharma Llc, Nuvo Pharms Inc, Pai Holdings Pharm, Hikma, Morton Grove, and Roxane, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for sodium polystyrene sulfonate. Eleven suppliers are listed for this compound.

Drug Prices for SODIUM POLYSTYRENE SULFONATE

See drug prices for SODIUM POLYSTYRENE SULFONATE

Recent Clinical Trials for SODIUM POLYSTYRENE SULFONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, IrvinePhase 4
Tris Pharma, Inc.Phase 4
Weill Medical College of Cornell UniversityPhase 4

See all SODIUM POLYSTYRENE SULFONATE clinical trials

US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms KIONEX sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 040028-001 Sep 17, 2007 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cmp Pharma Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 089910-001 Jan 19, 1989 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ani Pharms KIONEX sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040029-001 Feb 6, 1998 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ani Pharms SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 090590-001 May 13, 2011 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Baxter
Express Scripts
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.